Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXHL2500133	PF-07248144片	PF-07248144	Tablet	Chemical Drugs(1)	Import Drug Application	2025-06-12	Pfizer Inc;Pfizer Investment Co Ltd	view
JXHL2500134	PF-07248144片	PF-07248144	Tablet	Chemical Drugs(1)	Import Drug Application	2025-06-12	Pfizer Inc;Pfizer Investment Co Ltd	view
JXHL2500135	PF-07248144片	PF-07248144	Tablet	Chemical Drugs(1)	Import Drug Application	2025-06-12	Pfizer Inc;Pfizer Investment Co Ltd	view
JXHB2400020	PF-07248144片	PF-07248144	Tablet	Chemical Drugs(1)	Supplementary Application	2024-01-17	Pfizer Inc	view
JXHB2400021	PF-07248144片	PF-07248144	Tablet	Chemical Drugs(1)	Supplementary Application	2024-01-17	Pfizer Inc	view
JXHB2400022	PF-07248144片	PF-07248144	Tablet	Chemical Drugs(1)	Supplementary Application	2024-01-17	Pfizer Inc	view
JXHL2300024	PF-07248144片	PF-07248144	Tablet	Chemical Drugs(1)	Import Drug Application	2023-02-17	Pfizer Inc;Pfizer Investment Co Ltd	view
JXHL2300025	PF-07248144片	PF-07248144	Tablet	Chemical Drugs(1)	Import Drug Application	2023-02-17	Pfizer Investment Co Ltd	view